एपीए उद्धरण

Maiti, A., Qiao, W., Sasaki, K., Ravandi, F., Kadia, T. M., Jabbour, E. J., . . . Konopleva, M. Y. (2020). Venetoclax with Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-related Mortality. Am J Hematol.

शिकागो स्टाइल उद्धरण

Maiti, Abhishek, et al. "Venetoclax With Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified By Risk of Treatment-related Mortality." Am J Hematol 2020.

एमएलए उद्धरण

Maiti, Abhishek, et al. "Venetoclax With Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified By Risk of Treatment-related Mortality." Am J Hematol 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.